重组蛋白

重组蛋白质是分析生物相互作用的有用工具。在研究实验室中使用了大量的重组蛋白质,包括商业蛋白质和在特定研究项目中生成的蛋白质。它们在许多应用中发挥着关键作用。
如果您正在寻找具有优良质量(验证的生物活性,较低的内毒素水平和高纯度)的重组蛋白质来支持您的研究,您来对地方了。
经过16多年的发展,j9九游会登录入口首页生物已经建立了从原核到真核的五大系统,用于表达重组蛋白质。我们拥有一系列蛋白质表达和纯化技术,包括基于杆状病毒外膜蛋白(OMP)的蛋白质表达技术,以及膜蛋白表达技术等。
产品特点
- 超过10,000种重组蛋白覆盖大多数基因/靶点;
- 5种表达系统,包括大肠杆菌(E.coli)、酵母、杆状病毒感染的昆虫细胞、哺乳动物细胞和体外大肠杆菌。而体外大肠杆菌表达系统是j9九游会登录入口首页生物的独特表达系统。与传统蛋白表达系统相比,体外大肠杆菌省略了许多过程,如质粒转化、细胞培养、收集、破碎和离心等,大大提高了工作效率。
- 多种标签,包括His、GST、Flag、MBP等。
- 广泛应用,包括抗原、细胞分析、结合分析/蛋白质相互作用、细胞培养-无血清培养基、药物相关研究、体外酶活性、ELISA标准及其原料、体内研究、质谱标准、蛋白芯片、SDS-PAGE控制、蛋白质结构分析(晶体/电子显微镜)。
- 多种物种,包括人类、小鼠、大鼠、兔子、豚鼠、鸡、猴子、猪等。
- 无动物副产品的动物源性重组蛋白质。j9九游会登录入口首页生物已开发出无动物副产品接触的重组蛋白质产品线。
重组蛋白目录
以下是所有重组蛋白的目录。您可以在目录中找到适合您研究的蛋白质,或在本网站头部的搜索框中搜索它们。
如果您找不到您需要的抗体,请查看j9九游会登录入口首页生物蛋白质定制服务。
通过选择目标名称的首字母浏览产品。
产品名称 | 货号 | 规格 |
---|---|---|
Recombinant Methanocaldococcus jannaschii Pyridoxal biosynthesis lyase pdxS (pdxS) | CSB-YP710347MRU CSB-EP710347MRU CSB-BP710347MRU CSB-MP710347MRU CSB-EP710347MRU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Human Uncharacterized protein C2orf27 (C2orf27A) | CSB-YP710348HU CSB-EP710348HU CSB-BP710348HU CSB-MP710348HU CSB-EP710348HU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Methanocaldococcus jannaschii Imidazoleglycerol-phosphate dehydratase (hisB) | CSB-YP710349MRU CSB-EP710349MRU CSB-BP710349MRU CSB-MP710349MRU CSB-EP710349MRU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ0703 (MJ0703) | CSB-YP710350MRU CSB-EP710350MRU CSB-BP710350MRU CSB-MP710350MRU CSB-EP710350MRU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Methanocaldococcus jannaschii tRNA (guanine (10)-N2)-dimethyltransferase (MJ0710) | CSB-YP710351MRU CSB-EP710351MRU CSB-BP710351MRU CSB-MP710351MRU CSB-EP710351MRU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ0726 (MJ0726) | CSB-YP710352MRU CSB-EP710352MRU CSB-BP710352MRU CSB-MP710352MRU CSB-EP710352MRU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Methanocaldococcus jannaschii Iron-sulfur flavoprotein MJ0731 (MJ0731) | CSB-YP710353MRU CSB-EP710353MRU CSB-BP710353MRU CSB-MP710353MRU CSB-EP710353MRU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Methanocaldococcus jannaschii CoB--CoM heterodisulfide reductase subunit B 1 (hdrB1) | CSB-YP710354MRU CSB-EP710354MRU CSB-BP710354MRU CSB-MP710354MRU CSB-EP710354MRU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Methanocaldococcus jannaschii F420-0:gamma-glutamyl ligase (cofE) | CSB-YP710355MRU CSB-EP710355MRU CSB-BP710355MRU CSB-MP710355MRU CSB-EP710355MRU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ0776 (MJ0776), partial | CSB-YP710356MRU CSB-EP710356MRU CSB-BP710356MRU CSB-MP710356MRU CSB-EP710356MRU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ0783 (MJ0783) | CSB-YP710357MRU CSB-EP710357MRU CSB-BP710357MRU CSB-MP710357MRU CSB-EP710357MRU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ0790 (MJ0790), partial | CSB-YP710358MRU1 CSB-EP710358MRU1 CSB-BP710358MRU1 CSB-MP710358MRU1 CSB-EP710358MRU1-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Methanocaldococcus jannaschii Uncharacterized ABC transporter ATP-binding protein MJ0796 (MJ0796) | CSB-YP710359MRU CSB-EP710359MRU CSB-BP710359MRU CSB-MP710359MRU CSB-EP710359MRU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ0807 (MJ0807) | CSB-YP710360MRU CSB-EP710360MRU CSB-BP710360MRU CSB-MP710360MRU CSB-EP710360MRU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Methanocaldococcus jannaschii Putative uncharacterized protein MJ0821 (MJ0821) | CSB-YP710361MRU CSB-EP710361MRU CSB-BP710361MRU CSB-MP710361MRU CSB-EP710361MRU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ0830 (MJ0830) | CSB-YP710362MRU CSB-EP710362MRU CSB-BP710362MRU CSB-MP710362MRU CSB-EP710362MRU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ0836 (MJ0836) | CSB-YP710363MRU CSB-EP710363MRU CSB-BP710363MRU CSB-MP710363MRU CSB-EP710363MRU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Methanocaldococcus jannaschii Methyl-coenzyme M reductase I operon protein D (mcrD) | CSB-YP710364MRU CSB-EP710364MRU CSB-BP710364MRU CSB-MP710364MRU CSB-EP710364MRU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Methanocaldococcus jannaschii Tetrahydromethanopterin S-methyltransferase subunit D (mtrD), partial | CSB-YP710365MRU1 CSB-EP710365MRU1 CSB-BP710365MRU1 CSB-MP710365MRU1 CSB-EP710365MRU1-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ0859 (MJ0859) | CSB-YP710366MRU CSB-EP710366MRU CSB-BP710366MRU CSB-MP710366MRU CSB-EP710366MRU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
有用资源
什么是重组蛋白?
重组蛋白是一种可操纵的蛋白质形式,可以通过多种方式产生大量蛋白质、修改基因序列和制造有用的商业产品。重组蛋白的技术资源在重组蛋白的开发过程中,除了表达系统之外,还面临着一系列令人困惑的选择,如表达载体的选择、表达蛋白的长度(全长或部分)、是否带标签等。在生产重组蛋白时,你必须做出很多决定。如果你选择的明智,你将获得高质量的重组蛋白,后续的实验更有可能成功。但是如果你做了错误的决定,你可能得不到你所需要的重组蛋白或者重组蛋白的质量和纯度不符合要求。在这里,来自CUSABIO的蛋白表达工程师根据他们开发重组蛋白的经验总结出了几个有用的提示,可以帮助你做出明智的决策。
第一条:重组蛋白的生产,在这篇文章中,我们旨在阐明重组蛋白的定义以及如何生产重组蛋白。
第二条:如何选择合适的表达载体?
表达载体是一种DNA分子,它携带特定的基因进入宿主细胞,并利用细胞的蛋白质合成机制来产生由该基因编码的蛋白质。表达载体可使外源基因在宿主细胞中高效表达,经过多年的发展,表达载体已成为一种成熟而受欢迎的生物技术。在重组蛋白生产过程中是一种基本成分。正如标题所示,本文主要总结了几个有用的技巧来选择合适的表达载体。
第三条:如何表达具有生物活性的蛋白质?
根据重组蛋白的不同应用,对其生物活性有不同的要求。但是我们如何确保蛋白质的产生具有生物活性呢?本文将围绕这个主题,并提供一些解决方案。除了以上文章,我们还收集了一些重组蛋白的常见问题。您可以单击以下链接查看。/technology-91.html。此外,我们还为我们的客户提供重组蛋白表达服务,您可以点击这里获取更多信息。注:如果您对CUSABIO的蛋白质有任何疑问,涉及到蛋白质的价格、交货、质量等,您可以点击橙色按钮为我们在线留言。
引用资料
Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023
Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023
Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023
Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023
Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022